Herbolea Closes 5M€ Series A Round Led By Eu Cannabis Fund Oskare Capital And Bruce Linton
10/26/21, 11:05 AM
Industry
natural resources
internet services
Round Type
series a
Herbolea, an Italian company who develops and licenses proprietary, solventless technologies to transform botanicals into superior quality products, is happy to announce the closing of its 5m EUR Series A round, of which 2.5m EUR conditioned to milestone achievement, led by the European medical and pharmaceutical cannabis specialist fund, Óskare Capital. The funds will be used to accelerate growth, expand the team and extend access to core markets, in particular, the US.
Company Info
Additional Info
Herbolea Biotech is an Italian extraction technology company offering industrial solventless solutions to transform botanicals into superior quality products through proprietary, highly efficient, and environmentally friendly technologies. Visit www.herbolea.com to learn more or watch a video of our processes at https://www.youtube.com/watch?v=ZjLIds9FPkQ.
For more information, please contact: Lorenzo Venturini Del Greco by email lorenzo.venturini@herbolea.com or Marco Merciai, marco.merciai@herbolea.com, +393922655333